During the past decade, Prisma Health Cancer Institute - Laurens conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 16 clinical trials were completed, i.e. on average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 16 clinical trials were completed. i.e. 1600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prisma Health Cancer Institute - Laurens" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Wake Forest University Health Sciences" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Cancer Institute - Laurens" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health Cancer Institute - Laurens" are "Breast Carcinoma" (3 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Invasive Breast Carcinoma" (2 trials), "Malignant Neoplasm" (2 trials) and "Metastatic Malignant Neoplasm in the Brain" (2 trials). Many other conditions were trialed in "Prisma Health Cancer Institute - Laurens" in a lesser frequency.

Most popular intervention types in "Prisma Health Cancer Institute - Laurens" are "Other" (39 trials), "Drug" (32 trials), "Biological" (19 trials), "Procedure" (16 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (12 trials), "Questionnaire Administration" (9 trials), "Nivolumab" (8 trials) and "Biospecimen Collection" (7 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Cancer Institute - Laurens" are 43 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Prisma Health Cancer Institute - Laurens". undefined are not yet recruiting, 6 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Prisma Health Cancer Institute - Laurens, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Cancer Institute - Laurens, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".